Two nested case-control studies in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study and Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening trial found no association between pre-diagnostic circulating C-reactive protein concentrations and the risk of pancreatic cancer [4]. This evidence concerns the gene CRP and pancreatic neoplasm.